| Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416) |
|---|
| 02/11/2010 | US20100035991 Amide base salts of saha and polymorphis thereof |
| 02/11/2010 | US20100035958 Novel Compounds And Compositions Thereof |
| 02/11/2010 | US20100035930 UREA AND SULFAMIDE DERIVATIVES AS INHIBITORS OF TAFIa |
| 02/11/2010 | US20100035355 Method for the determination of body odor |
| 02/11/2010 | CA2732984A1 Process for production of bicyclo[2.2.2]octylamine derivative |
| 02/10/2010 | CN101646645A Fluoroalkyl surfactants |
| 02/10/2010 | CN101643430A Method for extracting seaweed organic iodine from seaweed or seaweed root |
| 02/09/2010 | US7659428 Methods for producing acylphenylalanine |
| 02/09/2010 | US7659424 Reacting an ester of an N-acylhydrazonoacetate and an allylating agent of allyl- or crotyltrichlorosilane using a chiral phosphine oxide, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl dioxide to obtain anenantioselectively product; chemical intermediate for amino acids, alloleucine |
| 02/09/2010 | US7659396 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency |
| 02/09/2010 | US7659364 Decyclization of an oxazolidinone compound; N-methylmethionine chemical intermediates |
| 02/09/2010 | US7659311 Delivery of agents such as heparin and calcitonin; greater efficacy; disodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid |
| 02/09/2010 | US7659301 Controlling photoactivation; reducing oxygen concentration of tissue at site; prevention metabolism; cooling |
| 02/09/2010 | CA2484954C 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 02/09/2010 | CA2410647C Substituted phenylpropanoic acid derivatives |
| 02/09/2010 | CA2386297C Bicyclic amino acids as pharmaceutical agents |
| 02/09/2010 | CA2202094C Process for producing sodium 1-thyroxine comprising the oxidative coupling of a diido-1-tyrosine catalysed by a manganese salt in the presence of an amine |
| 02/09/2010 | CA2201863C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitors |
| 02/04/2010 | US20100029983 Process for preparing gabapentin |
| 02/04/2010 | US20100029935 Optically active quaternary ammonium salt having axial asymmetry, and method for producing alpha-amino acid and derivative thereof by using the same |
| 02/04/2010 | US20100029768 Compositions and Methods For Promoting Fat Loss |
| 02/04/2010 | US20100029523 Lubricants derived from plant and animal oils and fats |
| 02/02/2010 | US7655666 Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands |
| 02/02/2010 | CA2358560C .alpha.-substitution of unprotected .beta.-amino ester compounds |
| 01/28/2010 | WO2010010174A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| 01/28/2010 | WO2010009630A1 A process for preparing r-beta-amino phenylbutyric acid derivatives |
| 01/28/2010 | US20100022795 Process for producing optically active beta-hydroxy-alpha-aminocarboxylic acid ester |
| 01/28/2010 | US20100022650 Benzamide Derivatives As EP4 Receptor Agonists |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022394 Products for the treatment of the iron chlorosis |
| 01/28/2010 | CA2734991A1 Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival |
| 01/28/2010 | CA2731245A1 A process for preparing r-beta-amino phenylbutyric acid derivatives |
| 01/28/2010 | CA2730208A1 1,1'-diadamantyl carboxylic acids, medicaments containing such compounds and their use |
| 01/27/2010 | EP2146951A2 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics |
| 01/27/2010 | CN101633626A L-m-aminophenyl glycine, derivatives, preparation method and application thereof |
| 01/27/2010 | CN101633625A Method for preparing R-beta-aminobenzene butyric acid derivative |
| 01/27/2010 | CN101633624A Preparation method of improved di-lysine-aspirin |
| 01/27/2010 | CN101633623A Method for extracting mulberry leaf gamma-aminobutyric acid and application thereof |
| 01/27/2010 | CN100584821C Method for preparing optically pure t-leucine |
| 01/27/2010 | CN100584807C Deuterated catecholamine derivatives and medicaments comprising said compounds |
| 01/26/2010 | US7652111 For preparing crosslinked swellable hydrogels; transesterification, distillation |
| 01/26/2010 | CA2319255C Pharmaceuticals comprising n,n'-bis(2- hydroxybenzyl) ethylenediamine-n, n'-diacetic acid for iron chelating therapy |
| 01/21/2010 | WO2010007964A1 Method for producing 6-aryloxyquinoline derivative and intermediate thereof |
| 01/21/2010 | WO2010006954A1 Novel n-substituted beta-amino acid esters |
| 01/21/2010 | WO2009145989A3 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 01/21/2010 | US20100016632 Biphenyl acetate, preparation and uses thereof |
| 01/21/2010 | US20100016631 Method for the synthesis of peptides without solvent |
| 01/21/2010 | US20100016403 Use of d-serine derivatives for the treatment of anxiety disorders |
| 01/21/2010 | US20100016379 Terephthalamate Compounds and Compositions, and Their Use as HIV Integrase Inhibitors |
| 01/21/2010 | US20100016295 Preparation and Use of Biphenyl Amino Acid Derivatives for the Treatment of Obesity |
| 01/21/2010 | US20100015249 Antitumor agent containing 6'-amidino-2'-naphthyl 4-guanidinobenzoate or salt thereof |
| 01/20/2010 | EP2145873A1 New compounds with activity that protects against the action of toxins and viruses in intracellular action mode |
| 01/20/2010 | CN101628878A N-hydroxymethylglycine phosphite, preparation thereof and application thereof |
| 01/20/2010 | CN100582088C Aminoalcohol derivatives |
| 01/20/2010 | CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 01/20/2010 | CN100582086C Compound towards target of cardiac muscle and preparation |
| 01/20/2010 | CN100582085C Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
| 01/19/2010 | USRE41084 Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methyl propionic acid (CCI-779) and 4-dimethylamino-but-2-enoic acid(4-(3-chloro-4-fluoro-phenylamino)-3-cyano-7-ethoxy-quinol in-6-yl)amide (EKB-569); synergistic; antitumor agents |
| 01/19/2010 | US7648971 Thrombopoietin mimetics |
| 01/14/2010 | WO2010005465A1 L-carnitine and alkanoyl l-carnitine phytates and process for preparing the same |
| 01/14/2010 | WO2010004220A2 Method for synthesising 9-aminononanoic acid or the esters thereof from natural unsaturated fatty acids |
| 01/14/2010 | WO2010004219A2 Method for synthesising omega-amino-alkanoic acids or the esters thereof from natural fatty acids |
| 01/14/2010 | US20100010234 Process for manufacturing a glutamic acid derivative and a pyroglutamic acid derivative and a novel intermediate in the manufacture thereof |
| 01/14/2010 | US20100010010 Hdac inhibitors |
| 01/14/2010 | US20100010000 Amino alcohol derivative and immunosuppresive agent having same as an active ingredient |
| 01/14/2010 | US20100009933 Hydroxylated amide skin moisturizer |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009426 synthetic or recombinant polypeptide having a nitrilase activity; have increased activity and stability at increased pH and temperature |
| 01/14/2010 | US20100009299 Resist composition and patterning process |
| 01/14/2010 | CA2730258A1 Mineral amino acid polysaccharide complex |
| 01/14/2010 | CA2727918A1 L-carnitine and alkanoyl l-carnitine phytates and process for preparing the same |
| 01/13/2010 | EP1831154B1 Preparation of pregabalin and related compounds |
| 01/13/2010 | EP1706501B1 Biochemical synthesis of 6-amino caproic acid |
| 01/13/2010 | EP1685092B1 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives |
| 01/13/2010 | EP1603863B1 Process for the preparation of amino methyl cyclo alkane acetic acids |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | EP1255725B1 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 01/13/2010 | CN101624351A Preparation method of DL-lysine |
| 01/13/2010 | CN101624350A Crystallization method of 5-aminolevulinic propionic hydrochloride |
| 01/13/2010 | CN101624349A Method for preparing serine |
| 01/12/2010 | US7645805 a core which is functionalized with three amino acid derived groups by means of an amide or urea linkage. It may be used to gelate or thicken numerous solvents |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645793 Effective ingredient and basic agent; foam suppression |
| 01/12/2010 | US7645770 Phenylalanine enamide derivatives |
| 01/12/2010 | CA2471105C Stable isotope-labeled amino acid and method for incorporating the same into target protein, nmr method for the structural analysis of protein and method for producing regio-selective stable isotope-labeled fumaric acid and tartaric acid |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010000856A1 Method for producing aminobiphenylene |
| 01/07/2010 | WO2010000066A1 Diglycidic ether derivative therapeutics and methods for their use |
| 01/07/2010 | WO2009138758A3 Bis-aryl compounds for use as medicaments |
| 01/07/2010 | US20100004485 Gabapentin enacarbil salts and processes for their preparation |
| 01/07/2010 | US20100004481 L-threonine derivatives of high therapeutic index |
| 01/07/2010 | US20100004336 comprising L-lysine-d-amphetamine hydrochloride salt; without spiking blood serum concentrations of amphetamine; sustained release; for treatment of attention deficit hyperactivity disorder, narcolepsy; bioavailability; reducing oral abuse liability |
| 01/07/2010 | US20100004332 Levodopa Prodrugs, and Compositions and Uses Thereof |
| 01/07/2010 | US20100004326 Metabolites of selective androgen receptor modulators and methods of use thereof |
| 01/07/2010 | CA2728223A1 Method for producing aminobiphenyls |
| 01/07/2010 | CA2728219A1 Diglycidic ether derivative therapeutics and methods for their use |
| 01/06/2010 | EP2139873A1 N-HETEROCYCLIC CARBENE CATALYZED SYNTHESIS OF N-PHENYLISOXAZOLIDIN-5-ONE DERIVATIVE AND SYNTHESIS OF ß-AMINO ACID ESTER DERIVATIVE |
| 01/06/2010 | CN101619027A Preparation method of levodopa butyl ester hydrochloride |
| 01/06/2010 | CN100577741C Reagent for detecting analyte |
| 01/06/2010 | CN100577652C Method for synthesizing esters of N-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |